First report of in vitro selection of RNA aptamers targeted to recombinant loxosceles laeta spider toxins

Biological Research

Volumn 47, Issue 1, 2014, Pages

  Sapag, Amalia ^a   Salinas Luypaert, Catalina ^a   Constenla Muñoz, Carlos ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Antivenom; Loxosceles laeta; RNA aptamers; SELEX; SMD ll1; SMD Ll2; Sphingomyelinase D

Indexed keywords

APTAMER; LOXOSCELES VENOM; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; SPHINGOMYELIN PHOSPHODIESTERASE D; SPIDER VENOM;

AFFINITY CHROMATOGRAPHY; ANIMAL; BROWN RECLUSE SPIDER; CLASSIFICATION; DIAGNOSTIC USE; DNA SEQUENCE; ENZYMOLOGY; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; PROCEDURES; SPIDER BITES;

ANIMALS; APTAMERS, NUCLEOTIDE; BROWN RECLUSE SPIDER; CHROMATOGRAPHY, AFFINITY; CLONING, MOLECULAR; GENE EXPRESSION; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; SEQUENCE ANALYSIS, DNA; SPIDER BITES; SPIDER VENOMS;

EID: 84902281992     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.1186/0717-6287-47-2     Document Type: Article

References (30)

1. Futrell JM: Loxoscelism. Am J Med Sci 1992, 304:261-267.
2. Hogan CJ, Barbaro KC, Winkel K: Loxoscelism: old obstacles, new directions. Ann Emerg Med 2004, 44:608-624.
3. Swanson DL, Vetter RS: Loxoscelism. Clin Dermatol 2006, 24:213-221.
4. Schenone H: Cuadros tóxicos producidos por mordeduras de araña en Chile: latrodectismo y loxoscelismo. Rev Med Chil 2003, 131:437-444.
5. Sezerino UM, Zannin M, Kowlaski Coelho L, Gonçalves J Jr, Grando M, Grossemann Mattosinho S, Costa Cardoso JL, von Eickstedt VR, Siqueira França FO, Barbaro KC, Fan HW: A clinical and epidemiological study of Loxosceles spider envenoming in Santa Catarina, Brazil. Trans R Soc Trop Med Hyg 1998, 92:546-548.
6. Chaim OM, Trevisan-Silva D, Chaves-Moreira D, Wille ACM, Pereira Ferrer V, Matsubara FH, Mangili OC, Bertoni da Silveira R, Gremski LH, Gremski W, Senff-Ribeiro A, Saches Veiga S: Brown spider (Loxosceles genus) venom toxins: tools for biological purposes. Toxins (Basel) 2011, 3:309-344.
7. Tambourgi DV, Magnoli FC, van den Berg CW, Morgan BP, de Araujo PS, Alves EW, Dias Da Silva W: Sphingomyelinases in the venom of the spider Loxosceles intermedia are responsible for both dermonecrosis and complement-dependent hemolysis. Biochem Biophys Res Commun 1998, 251:366-373.
8. Fernandes-Pedrosa de M F, de LM, Jd AI, Gonçalves-de-Andrade RM, van den Berg CW, Ramos CRR, Ho PL, Tambourgi DV: Molecular cloning and expression of functional dermonecrotic and haemolytic factor from Loxosceles laeta venom. Biochem Biophys Res Commun 2002, 298:638-645.
9. Tambourgi DV, Magnoli FC, Von Eickstedt VRD, Benedetti ZC, Petricevich VL, Dias da Silva W: Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway. J Immunol 1995, 155:4459-4466.
10. Tambourgi DV, Gonçalves-de-Andrade RM, van den Berg CW: Loxoscelism: from basic research to the proposal of new therapies. Toxicon 2010, 56:1113-1119.
11. Catalán A, Cortes W, Sagua H, González J, Araya JE: Two new phospholipase D isoforms of Loxosceles laeta: cloning, heterologous expression, functional characterization, and potential biotechnological application. J Biochem Mol Toxicol 2011, 25:393-403.
12. de Santi Ferrara GI, Fernandes-Pedrosa de M F, de LM, Jd A I, Gonçalves-de-Andrade RM, Portaro FCV, Manzoni-de-Almeida D, Murakami MT, Arni RK, van den Berg CW, Ho PL, Tambourgi DV: SMase II, a new sphingomyelinase D from Loxosceles laeta venom gland: molecular cloning, expression, function and structural analysis. Toxicon 2009, 53:743-753.
13. Olvera A, Ramos-Cerrillo B, Estévez J, Clement H, de Roodt A, Paniagua-Solís J, Vázquez H, Zavaleta A, Salas Arruz M, Stock RP, Alagón A: North and South American Loxosceles species: development of a polyvalent antivenom with recombinant sphingomyelinases D as antigens. Toxicon 2006, 48:64-74.
14. Araujo SC, Castanheira P, Alvarenga LM, Mangili OC, Kalapothakis E, Chávez- Olórtegui C: Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein. Toxicon 2003, 41:261-267.
15. Ramos-Cerrillo B, Olvera A, Odell GV, Zamudio F, Paniagua-Solís J, Alagón A, Stock RP: Genetic and enzymatic characterization of shingomyelinase D isoforms from the North American fiddleback spiders Loxosceles boneti and Loxosceles reclusa. Toxicon 2004, 44:507-514.
16. Senff-Ribeiro A, da Silva PH, Chaim OM, Gremski LH, Paludo KS, Bertoni da Silveira R, Gremski W, Mangili OC, Sanches Veiga S: Biotechnological applications of brown spider (Loxosceles genus) venom toxins. Biotechnol Adv 2008, 26:210-218.
17. Manzoni de Almeida D, Fernandes-Pedrosa de M F, de Andrade RM G, Marcelino J, Gondo-Higashi H, de LM, Jd AI, Ho PL, van den Berg C, Tambourgi DV: A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials. Am J Trop Med Hyg 2008, 79:463-470.
18. Alvarenga LM, Martins MS, Moura JF, Kalapothakis E, Oliveira JC, Mangili OC, Granier C, Chávez-Olórtegui C: Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay. Toxicon 2003, 42:725-731.
19. Guilherme P, Fernandes I, Barbaro KC: Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies. Toxicon 2001, 39:1333-1342.
20. Barbaro KC, Knysak I, Martins R, Hogan C, Winkel K: Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas. Toxicon 2005, 45:489-499.
21. Gomez HF, Miller MJ, Waggener MW, Lankford HA, Warren JS: Antigenic cross-reactivity of venoms from medically important North American Loxosceles spider species. Toxicon 2001, 39:817-824.
22. Tambourgi DV, Fernandes-Pedrosa de M F, van den Berg CW, Gonçalves-de- Andrade RM, Ferracini M, Paixão-Cavalcante D, Morgan BP, Rushmere NK: Molecular cloning, expression, function and immunoreactivities of members of a gene family of sphingomyelinases from Loxosceles venom glands. Mol Immunol 2004, 41:831-840.
23. Keefe AD, Pai S, Ellington A: Aptamers as therapeutics. Nat Rev Drug Discov 2010, 9:537-550.
24. Stoltenburg R, Reinemann C, Strehlitz B: SELEX-A (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng 2007, 24:381-403.
25. Murakami MT, Fernandes-Pedrosa MF, Tambourgi DV, Arni RK: Structural basis for metal ion coordination and the catalytic mechanism of sphingomyelinase D. J Biol Chem 2005, 280:13658-13664.
26. Lauridsen LH, Veedu RN: Nucleic acid aptamers against biotoxins: a new paradigm toward the treatment and diagnostic approach. Nucleic Acid Ther 2012, 22:371-379.
27. Citartan M, Gopinath SCB, Tominaga J, Tan S-C, Tang T-H: Assays for aptamer-based platforms. Biosens Bioelectron 2012, 34:1-11.
28. Xiong A-S, Yao Q-H, Peng R-H, Duan H, Li X, Fan H-Q, Cheng Z-M, Li Y: PCR-based accurate synthesis of long DNA sequences. Nat Protoc 2006, 1:791-797.
29. Sapag A, Draper DE: In vitro evolution used to define a protein recognition site within a large RNA domain. Bioorg Med Chem 1997, 5:1097-1105.
30. Thompson JD, Higgins DG, Gibson TJ, Clustal W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.